NVCT
Nuvectis Pharma, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $23.73
- As of
Share the NVCT intelligence card
See NVCT live in the terminal
Track NVCT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live NVCT terminal, freeActive signals for NVCT
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +697% to NVCT (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +252% to NVCT (2026Q2)
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 12.3%, EPS $-0.30 vs $-0.2672 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 17.8% - EPS $-0.26 vs $-0.3162 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 15.3% - EPS $-0.3 vs $-0.2601 estimate
FREE, NO ACCOUNT
Every signal on NVCT, as it fires
You are seeing 5 of 6 signals recorded on NVCT since 2026-05-31.
The five above landed across 3 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Top institutional holders of NVCT (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLC | $526K | 0.00% | , |
| CITADEL ADVISORS LLC | $289K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLC | $258K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $111K | 0.00% | , |
| CITADEL ADVISORS LLC | $109K | 0.00% | -83.4% |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, NVCT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
Related tickers
See more NVCT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NVCTand get the insider, 13F, options, and confluence read in one view.